Morphoceuticals

Ownership

Private

Therapeutic Areas

OtherDermatology

Stage

Preclinical

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

ElectroceuticalsAI-guided regenerative medicine

Morphoceuticals General Information

Developing technology to modulate ion channels as a conduit for bioelectric signaling to enable tissue repair and organ regeneration

Contact Information

Website

https://www.morphoceuticals.com/

Primary Industry

Therapeutic Medical Devices

Corporate Office

Marblehead, Massachusetts
United States

Drug Pipeline

No pipeline data available

For full access to Morphoceuticals's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Morphoceuticals Funding

Deal Type	Date	Amount	Status	Stage
Investment	Apr 18, 2024	$10.0M	Completed	Preclinical

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Morphoceuticals's complete valuation and funding history, request access »

Morphoceuticals Financial Metrics